Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator.
The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial Cl- channel
regulated by protein kinase A. The most common mutation in cystic fibrosis (CF), deletion of …
regulated by protein kinase A. The most common mutation in cystic fibrosis (CF), deletion of …
[HTML][HTML] A low-gluten diet induces changes in the intestinal microbiome of healthy Danish adults
Adherence to a low-gluten diet has become increasingly common in parts of the general
population. However, the effects of reducing gluten-rich food items including wheat, barley and …
population. However, the effects of reducing gluten-rich food items including wheat, barley and …
Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective …
…, TH Haupt, G Ellekilde, JH Poulsen… - Emergency Medicine …, 2016 - emj.bmj.com
Objective Soluble urokinase plasminogen activator receptor (suPAR) is an inflammatory
biomarker associated with presence and progression of disease and with increased risk of …
biomarker associated with presence and progression of disease and with increased risk of …
Transjugular intrahepatic portosystemic shunt: impact on systemic hemodynamics and renal and cardiac function in patients with cirrhosis
TM Busk, F Bendtsen, JH Poulsen… - American Journal …, 2018 - journals.physiology.org
Transjugular intrahepatic portosystemic shunt (TIPS) alleviates portal hypertension and
possibly increases central blood volume (CBV). Moreover, renal function often improves; …
possibly increases central blood volume (CBV). Moreover, renal function often improves; …
Evaluation of clinical assays for measuring high-dose methotrexate in plasma
F Albertioni, C Rask, S Eksborg, JH Poulsen… - Clinical …, 1996 - academic.oup.com
Four routine assays commonly used for monitoring plasma methotrexate (MTX) during high-dose
therapy were validated by HPLC as the comparison method. MTX and its main …
therapy were validated by HPLC as the comparison method. MTX and its main …
Lacrimal gland electrolyte and water secretion in the rabbit: localization and role of (Na++ K+)‐activated ATPase.
DA Dartt, M Møller, JH Poulsen - The Journal of Physiology, 1981 - Wiley Online Library
1. The rate of acetylcholine (ACh)‐induced fluid secretion was measured from the main
secretory duct of rabbit lacrimal glands perfused in vivo with Krebs Henseleit bicarbonate …
secretory duct of rabbit lacrimal glands perfused in vivo with Krebs Henseleit bicarbonate …
Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement.
…, K Stengaard-Pedersen, JH Poulsen - The Journal of …, 2004 - jrheum.org
OBJECTIVE: To investigate the effect of methotrexate (MTX) treatment of rheumatoid arthritis
(RA) on folate metabolism, and to determine the effect of low dose folic acid on toxicity, …
(RA) on folate metabolism, and to determine the effect of low dose folic acid on toxicity, …
Combined alcian blue and silver staining of subnanogram quantities of proteoglycans and glycosaminoglycans in sodium dodecyl sulfate-polyacrylamide gels
HJ Moller, D Heinegard, JH Poulsen - Analytical biochemistry, 1993 - Elsevier
Proteoglycans stain weakly in polyacrylamide gels by traditional protein stains such as
coomassie brilliant blue or silver. In the present work preparations of large aggregating …
coomassie brilliant blue or silver. In the present work preparations of large aggregating …
Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical …
…, K Stengaard-Pedersen, JH Poulsen - The Journal of …, 2008 - jrheum.org
Objective To investigate the accumulation of methotrexate (MTX) in circulating erythrocytes
and the association with pharmacokinetic variables, weekly dose, and clinical efficacy in 2 …
and the association with pharmacokinetic variables, weekly dose, and clinical efficacy in 2 …
Citalopram: interaction studies with levomepromazine, imipramine, and lithium
…, SH Sindrup, K Brøsen, JH Poulsen… - Therapeutic drug …, 1993 - journals.lww.com
The pharmacokinetic interactions between the selective serotonin reuptake inhibitor citalopram,
given as an oral dose of 40 mg/day for 10 days, and (1) levomepromazine (50 mg single …
given as an oral dose of 40 mg/day for 10 days, and (1) levomepromazine (50 mg single …